Finance News – Regeneron
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
23andMe back on the auction block after former CEO makes 11th-hour bid
The recent $305 million offer from a principal insider disrupted a prior $256 million purchase deal, potentially altering the financial outcome of the company’s bankruptcy asset sa...
Read Full Article →S&P 500 Gains & Losses Today: Ulta Beauty Stock Soars; Regeneron Shares Plummet
Today’s market showed notable fluctuations as Ulta Beauty experienced a substantial increase in value, while Regeneron’s stock faced significant declines, impacting investor portfo...
Read Full Article →Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure
The unsuccessful outcome of Regeneron’s advanced COPD therapy study led to a significant decline in its stock value, marking the company’s largest drop in over a decade on financia...
Read Full Article →Top Stock Movers Now: Regeneron, Ulta Beauty, Cooper, and More
Several companies, including Regeneron, Ulta Beauty, and Cooper, experienced notable shifts in their stock prices today, reflecting changing investor sentiment and market dynamics...
Read Full Article →Struggling DNA testing firm 23andMe to be bought for $256m
The acquisition of 23andMe by Regeneron for $256 million highlights a notable investment in the genetic testing industry while ensuring continued commitment to safeguarding consume...
Read Full Article →